| Trial ID: | L0578 |
| Source ID: | IRCT2015120819554N10
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Compare the effects of pioglitazone with fenofibrate in treatment of patients with NAFLD
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic steatohepatitis. <br>Other specified inflammatory liver diseases, Nonalcoholic steatohepatitis [NASH];Other specified inflammatory liver diseases, Nonalcoholic steatohepatitis [NASH]
|
| Interventions: |
Intervention 1: Tab pioglitazone 30 mg once a day. Intervention 2: Tab fenofibrat 200 mg once aday.;Treatment - Drugs;Treatment - Drugs;Tab pioglitazone 30 mg once a day;Tab fenofibrat 200 mg once aday
|
| Outcome Measures: |
ALT. Timepoint: once at the begining and the second time after twelve weeks. Method of measurement: ELIZA.;FBS. Timepoint: once at the begining and the second time after twelve weeks. Method of measurement: ELIZA.;Lipid profile. Timepoint: once at the begining and the second time after twelve weeks. Method of measurement: ELIZA.Improve fatty liver. Timepoint: once at the begining and the second time after twelve weeks. Method of measurement: Specific liver enzyme tests.
|
| Sponsor/Collaborators: |
Vice Chancellor for research, Zanjan University Of Medical Sciences
|
| Gender: |
All
|
| Age: |
30 years55 years
|
| Phases: |
Phase 3
|
| Enrollment: |
90
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
12/07/2016
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/17479
|
